VACCINEX, INC. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vaccinex, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Vaccinex, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.55M, a 22% increase year-over-year.
  • Vaccinex, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$20.3M, a 11.6% increase year-over-year.
  • Vaccinex, Inc. annual Operating Income (Loss) for 2023 was -$22.9M, a 15% decline from 2022.
  • Vaccinex, Inc. annual Operating Income (Loss) for 2022 was -$19.9M, a 11.5% increase from 2021.
  • Vaccinex, Inc. annual Operating Income (Loss) for 2021 was -$22.5M, a 20.6% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$22.9M -$2.98M -15% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-04-25
2022 -$19.9M +$2.58M +11.5% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-04-25
2021 -$22.5M +$5.84M +20.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$28.3M +$3.68M +11.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$32M -$4.73M -17.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$27.3M -$6.18M -29.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 -$21.1M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.